Hiran Orgochem Ltd vs Sun Pharmaceutical Industries Limited

A side-by-side comparison of Hiran Orgochem Ltd (506170) and Sun Pharmaceutical Industries Limited (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Sun Pharmaceutical Industries Limited leads 506170 vs SUNPHARMA on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth01
  • Size & financial health13

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
36.79
0.00
P/B ratio
5.35
0.00%
Dividend yield
0.86%
₹-2.81
EPS
₹47.80

Profitability

SUNPHARMA takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

0.00%
Return on equity
13.74%
-26.09%
Return on capital
17.46%
-1880.95%
EBITDA margin
30.33%
-6609.52%
Net margin
19.69%

Growth

SUNPHARMA takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

-77.90%
Revenue CAGR (3Y)
10.03%
—
Profit CAGR (3Y) even
10.57%

Size & financial health

SUNPHARMA takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹4.22L Cr
₹0 Cr
Revenue
₹58,462 Cr
₹-28 Cr
Net profit
₹11,509 Cr
0.00
Debt / equity
0.06
Hiran Orgochem Ltd
  • + ["Company has reduced debt."]
  • − ["The company has delivered a poor sales growth of -70.9% over past five years.", "Company has high debtors of 322 days.", "Working capital days have increased from 1,638 days to 2,355 days"]
Sun Pharmaceutical Industries Limited
  • + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
  • − ["Stock is trading at 5.05 times its book value"]
Hiran Orgochem Ltd full analysis Sun Pharmaceutical Industries Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

506170 vs SUNPHARMA: Share Price, Valuation & Which to Buy | DocStoX